83.21
-1.00 (-1.19%)
| Penutupan Terdahulu | 84.21 |
| Buka | 84.21 |
| Jumlah Dagangan | 1,146,513 |
| Purata Dagangan (3B) | 1,062,468 |
| Modal Pasaran | 13,100,332,032 |
| Harga / Pendapatan (P/E TTM) | 49.53 |
| Harga / Pendapatan (P/E Ke hadapan) | 32.79 |
| Harga / Jualan (P/S) | 8.50 |
| Harga / Buku (P/B) | 5.17 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 Aug 2023 - 7 Aug 2023 |
| Hasil Dividen (DY TTM) | 0.55% |
| Margin Keuntungan | 10.89% |
| Margin Operasi (TTM) | 14.10% |
| EPS Cair (TTM) | 0.830 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -54.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 20.99% |
| Nisbah Semasa (MRQ) | 3.71 |
| Aliran Tunai Operasi (OCF TTM) | 264.85 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 244.41 M |
| Pulangan Atas Aset (ROA TTM) | 5.23% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.53% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Bio-Techne Corp | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -2.13 |
|
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 1.07% |
| % Dimiliki oleh Institusi | 106.11% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 80.00 (TD Cowen, -3.86%) | Beli |
| Median | 69.00 (-17.08%) | |
| Rendah | 65.00 (Stifel, -21.88%) | Pegang |
| Purata | 71.67 (-13.87%) | |
| Jumlah | 4 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 62.10 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Evercore ISI Group | 05 Feb 2026 | 68.00 (-18.28%) | Pegang | 63.92 |
| 05 Jan 2026 | 62.00 (-25.49%) | Pegang | 63.03 | |
| Stifel | 05 Feb 2026 | 65.00 (-21.88%) | Pegang | 63.92 |
| TD Cowen | 05 Feb 2026 | 80.00 (-3.86%) | Beli | 63.92 |
| UBS | 05 Feb 2026 | 79.00 (-5.06%) | Beli | 63.92 |
| 06 Nov 2025 | 70.00 (-15.88%) | Beli | 58.18 | |
| Argus Research | 20 Nov 2025 | 68.00 (-18.28%) | Beli | 58.73 |
| Wells Fargo | 06 Nov 2025 | 70.00 (-15.88%) | Beli | 58.18 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |